Associated Papers
Analysis of 75 Candidate SNPs Associated With Acute Rejection in Kidney Transplant Recipients: Validation of rs2910164 in MicroRNA MIR146A.
Oetting WS et al.
Transplantation, 2019
SLCO1B1 Polymorphisms are Associated With Drug Intolerance in Childhood Leukemia Maintenance Therapy.
Eldem İ et al.
Journal of Pediatric Hematology/oncology, 2018
Genetics of acute rejection after kidney transplantation.
Dorr CR et al.
Transplant International : Official Journal of the European Society for Organ Transplantation, 2018
Associations between polymorphisms in target, metabolism, or transport proteins of mycophenolate sodium and therapeutic or adverse effects in kidney transplant patients.
Woillard JB et al.
Pharmacogenetics and Genomics, 2014
Validation of single nucleotide polymorphisms associated with acute rejection in kidney transplant recipients using a large multi-center cohort.
Oetting WS et al.
Transplant International : Official Journal of the European Society for Organ Transplantation, 2011
Inter-ethnic variability of three functional polymorphisms affecting the IMPDH2 gene.
Garat A et al.
Molecular Biology Reports, 2011
The influence of pharmacogenetics and cofactors on clinical outcomes in kidney transplantation.
Picard N et al.
Expert Opinion on Drug Metabolism & Toxicology, 2011
An inosine 5'-monophosphate dehydrogenase 2 single-nucleotide polymorphism impairs the effect of mycophenolic acid.
Winnicki W et al.
The Pharmacogenomics Journal, 2010
IMPDH2 genetic polymorphism: a promoter single-nucleotide polymorphism disrupts a cyclic adenosine monophosphate responsive element.
Garat A et al.
Genetic Testing and Molecular Biomarkers, 2009
A novel variant L263F in human inosine 5'-monophosphate dehydrogenase 2 is associated with diminished enzyme activity.
Wang J et al.
Pharmacogenetics and Genomics, 2007
Select a paper to view details